Table 2.
Patient characteristics
| Variable | Baseline value (N = 204) |
|---|---|
| Age, years, mean (SD) | 70.5 (10.9) |
| Sex, n (%) | |
| Male | 138 (67.6) |
| Female | 66 (32.4) |
| Type of MI, n (%) | |
| NSTEMI | 127 (62.3) |
| STEMI | 77 (37.7) |
| SPM, n (%) | |
| Aspirin | 190 (93.1) |
| Other antiplatelet agent | 192 (94.1) |
| Ticagrelor (twice daily) | 159 (77.9) |
| ACE inhibitor / ARB | 188 (92.2) |
| Twice daily dosing | 44 (21.6) |
| Beta-blocker | 180 (88.2) |
| Twice daily dosing | 23 (11.3) |
| Statin | 192 (94.1) |
| SPM administration times,* n (%) | |
| One regular administration time per day | 5 (2.5) |
| Two regular administration times per day | 147 (72.1) |
| Three regular administration times per day | 40 (19.6) |
| Not completed | 12 (5.9) |
N = 204. *The total number of times the patient had to take a medicine, regardless of the number of medicines taken at the point of administration (i.e. more than one medicine may have been taken at each administration time). ACE Angiotensin converting enzyme, ARB Angiotensin II receptor blocker, NSTEMI non-ST-elevation myocardial infarction, MI Myocardial infarction, SD Standard deviation, SPM Secondary prevention medicine, STEMI ST-elevation myocardial infarction